Government of India bans Fixed dose combination of Glucosamine, Ibuprofen

Published On 2017-06-17 04:06 GMT   |   Update On 2017-06-17 04:06 GMT

Department of Health and Family Welfare of Ministry of Health and Family Welfare, Government of India has banned fixed dose combinations of Glucosamine + Ibuprofen after finding that the said drug lacks rationality and therapeutic justification.


Through a gazette notification, the Central government has banned the fixed dose combination of Glucosamine + Ibuprofen announcing that the drug fixed dose combination of Glucosamine + Ibuprofen is not rational.


The decision was announced after the matter has been examined by the Subject Expert Committee constituted by the Central Government and the said Committee recommended to the Central Government that the said drug lacks rationality and therapeutic justification;


After examination of the recommendations of the aforesaid Committee, the Central Government stated that it is satisfied that it is necessary and expedient in public interest to regulate by way of prohibition, the manufacture for sale, sale and distribution for human use of the said drug in the country; and hence prohibited the manufacture for sale, sale and distribution for human use of the drug fixed dose combination of Glucosamine + Ibuprofen with immediate effect.


Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News